{
    "2018-01-24": [
        [
            {
                "time": "2018-01-03",
                "original_text": "Is a Beat in the Cards for AbbVie (ABBV) in Q4 Earnings?",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Q4 Earnings",
                        "Beat"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-04",
                "original_text": "3 Stocks to Help You Build Retirement Wealth",
                "features": {
                    "keywords": [
                        "Stocks",
                        "Retirement Wealth"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "2018-01-05",
                "original_text": "See Which Of The Latest 13F Filers Holds AbbVie",
                "features": {
                    "keywords": [
                        "13F Filers",
                        "AbbVie"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-06",
                "original_text": "The Zacks Analyst Blog Highlights: AbbVie, Merck & Co., and AstraZeneca",
                "features": {
                    "keywords": [
                        "Zacks Analyst Blog",
                        "AbbVie",
                        "Merck & Co.",
                        "AstraZeneca"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-07",
                "original_text": "Novartis (NVS) Q4 Earnings & Sales Top on Cosentyx, Entresto",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Q4 Earnings",
                        "Sales",
                        "Cosentyx",
                        "Entresto"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-08",
                "original_text": "Novartis Announces Positive Results on Migraine Candidate",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Positive Results",
                        "Migraine Candidate"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-09",
                "original_text": "Will Core Segmental Growth Aid Stryker (SYK) in Q4 Earnings?",
                "features": {
                    "keywords": [
                        "Core Segmental Growth",
                        "Stryker",
                        "Q4 Earnings"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "medical devices"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}